← Back to catalogue

TDM/B-Hydroxybutyrate Bi-Level Controls

FDA UDI

Class I (US FDA UDI)

by Stanbio Laboratory, L.p.

Identity

Trade Name
TDM/B-Hydroxybutyrate Bi-Level Controls FDA UDI
Generic Name
Beta-hydroxybutyrate IVD, control FDA UDI
Device Name
For Use as Controls in Quantitative Procedures for Acetaminophen, Salicylate, and ß-Hydroxybutyrate. FDA UDI
Model / Reference
2465-605 FDA UDI
Description
For Use as Controls in Quantitative Procedures for Acetaminophen, Salicylate, and ß-Hydroxybutyrate. FDA UDI

Identifiers

Catalog Number
2465-605 FDA UDI
Primary DI / UDI-DI
00657498000540 FDA UDI
FDA Product Code
DIF FDA UDI
GMDN Term
Beta-hydroxybutyrate IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.3280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Beta-hydroxybutyrate IVD, control

TDM/B-Hydroxybutyrate Bi-Level Controls by Stanbio Laboratory, L.p. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Beta-hydroxybutyrate IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI f0362d7a-0287-47de-8ae7-6173bbfdb64c 36 fields · synced May 30, 2026